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• Because osteomyelitis is an infection 
of the bone, a precursor infection 
must occur in which the pathogenic 
bacteria transfer from a soft tissue 
injury to the bone in closest 
proximity.   
• The preceding symptoms of infection 
would be the same as any infection 
including warm, redness and 
tenderness at the site.  At times, 
fever accompanies infection.   
• Hatzenbuehler and colleagues from 
the American Academy of Family 
Physicians state that symptoms of 
osteomyelitis itself may not present 
for approximately two weeks after 
the invading pathogens get to the 
bone (Hatzenbuehler & Pulling, 2011, 
p. 1027).   
• It is stated that necrotic bone from 
osteomyelitis may not occur for six 
weeks after onset of infection 
(Hatzenbuehler & Pulling, 2011, p. 
1027).  
•  “Clinical symptoms include chronic 
pain, persistent sinus tract or wound 
drainage, poor wound healing, and 
sometimes fever” (Hatzenbuehler & 
Pulling, 2011, p. 1028).   
• Osteomyelitis is also often associated 
with diabetes and peripheral 
vascular disease.  These two 
conditions make a person more 
susceptible to wounds of the 
extremities because of neuropathy, 
unawareness of a wound and 
decreased blood flow resulting in 
poor wound healing and ultimately 
the opportunity for further infection. 
Osteomyelitis is an infection of the bone 
caused by either bacteria, fungi, 
parasites, viruses or mycobacteria 
(McCance, et. al., 2014).  The infection 
can enter bone either through an outside 
source or through the blood from a blood 
borne infection (McCance, et. al., 2014).  
The most common bacteria involved with 
osteomyelitis is Staphylococcus aureus 
(Hatzenbuehler & Pulling, 2011, p. 1027).  
Recently, at Dublin Methodist Hospital 
there has been an increase in the number 
of osteomyelitis cases in chronic 
uncontrolled diabetic patients requiring 
below the knee amputations.  Two of the 
cases specifically were linked to chronic 
diabetic foot ulcers.  Each of these cases 
were only planned to be partial foot 
amputations but resulted in below the 
knee amputations causing much stress 
for the patients and families.  Diabetics 
are highly susceptible to diabetic foot 
ulcers and subsequent infections for two 
reasons.  The first reason is that they 
have peripheral neuropathy and thus 
may not be able to feel a trauma to their 
foot or limb; and, secondly, because they 
have peripheral vascular disease limiting 
blood flow and thus healing to a wound 
site (Hatzenbuehler & Pulling, 2011, p. 
1028).  The pathophysiology of 
osteomyelitis is linked to bone 
degeneration and often the infection 
itself can be prevented with adequate 
and proactive nursing care.  New ways to 
diagnosis and treat osteomyelitis are 
being explored through new research as 
will be examined in this research poster.  
Implications for better patient care and 
prevention will be obtained through 
gathering of the research 
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Osteomyelitis can be difficult to 
diagnose and treat so clinicians must be 
aware of the special care that these 
patients require (Lipsky, et. al., 2012, p. 
1679).  Treatment and diagnosis need to 
be based on current knowledge of the 
pathophysiology of osteomyelitis and 
targeted specifically towards that.  Special 
nursing care and education can be given to 
diabetic patients at risk for developing 
osteomyelitis to maintain adequate 
glycemic control.  These patients also 
require specific follow up after suffering 
from osteomyelitis to be sure that it does 
not reoccur including good wound care, a 
completed antibiotic therapy course and 
follow ups with specialist.  A 
multidisciplinary foot team can help 
improve patient and hospital outcomes 
(Lipsky, et. al., 2012, p. 1679).  
 
Conclusions 
Significance of Pathophysiology 
Signs and 
Symptoms  
Underlying 
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The pathophysiology of osteomyelitis 
starts with some sort of insult to the 
bone whether that be hematologic in 
origin or from a proximal wound of a 
diabetic ulcer.  The original insult will  
spreads to the deeper structures and 
finally to the bone (Malone, Gannass, et. 
al. 2013, p. 318).  Staphylococcus aureus 
is the most common invading pathogen 
that causes osteomyelitis.  As with any 
other infections, the pathological 
process with osteomyelitis includes 
“synthesis of proinflammatory cytokines, 
activation and mobilization of phagocytic 
cells, thrombosis, [and] necrosis” and in 
osteomyelitis specifically: “bone 
sequestration, and formation of new 
bone” occur (Grbic, et. al., 2014, p. 1).   
S. aureus is capable of interacting with 
osteoblasts, bone-forming agents in 
bones, to alter bone reabsorption 
(Cassat, et. al., 2013).  One mechanism 
that occurs is that S. aureus causes 
osteoclastogenesis, or the production of 
osteoclasts which are bone-reabsorbing 
cells through the expression of 
proinflammatory cytokines and the 
osteoclast-activator molecule receptor 
system (RANK-L) (Cassat, et. al., 2013, p. 
759).  And secondly, the invasion of S. 
aureus-infected osteoclasts causes cell 
death (Cassat, et. al., 2013, p. 760).  
Cassat and colleagues who explored the 
pathophysiology of osteomyelitis in 
depth state that “pathogen-induced 
bone destruction…destroys the vascular 
architecture of the infected bone and 
limits antimicrobial penetration to the 
infectious focus (Cassat, et. al., 2013, p. 
766).  Furthermore, Cassat and 
colleagues summarize their findings by 
stating that “S. aureus induces profound 
changes in bone remodeling, in part 
through the production of osteolytic 
exoproteins that modulate osteoblast 
proliferation…suggesting that bacterial 
modulation of bone remodeling involves 
complex changes in bone physiology” 
(Cassat, et. al., 2013, p. 766).  Finally, 
damage is done to the bone in 
osteomyelitis by the oxidative stress that 
is produced by highly reactive oxidants 
of the leukocytes that move to the site 
of infection.   Oxidative stress has been 
found to increase osteoclast activity and 
suppress the maturation of osteoblasts 
further increasing harmful bone 
remodeling (Grbic, et. al., 2014, p. 1).  
The significance of the pathophysiology of osteomyelitis lies in the implications that the 
infectious process has for treatment, diagnosis and nursing and medical care.  Treatment of 
osteomyelitis is complicated by the pathogen-induced bone destruction and remodeling and 
therapies should target limiting the bone destruction that does occur (Cassat, et. al., 2013, p. 
766).  Cassat and colleagues at the Vanderbilt University Health System developed a bone 
model to support the theory that therapy needs to be targeted at bone physiology rather 
that only at antibiotic treatment with immune therapies that limit pathologic bone 
remodeling during osteomyelitis (Cassat, et. al., 2013, p. 768).  This produces significant 
implications for treatment preferences and options.  The preferred method of treatment for 
osteomyelitis is long term intravenous antibiotics.  The appropriate antibiotic to use is 
determined by results of wound or bone cultures and biopsies (Hatzenbuehler & Pulling, 
2011, p. 1031).  Intravenous therapy should continue for two to six weeks with a transition to 
oral antibiotics (Hatzenbuehler & Pulling, 2011, p. 1032).  It has been found that intravenous 
vancomycin is the first drug of choice for treatment of osteomyelitis (Hatzenbuehler & 
Pulling, 2011, p. 1032).  Furthermore, since the pathophysiology of osteomyelitis does 
involve altered bone remodeling the gold standard in diagnosis has been bone biopsies 
(Malone, Bowling, et. al, 2013, p. 547).  Bone biopsies, though, are expensive and painful for 
patients so other alternatives for diagnosis need to be found based on the pathophysiology 
discovered (Malone, Bowling, et. al, 2013, p. 547).  Malone and colleagues found that “deep 
wound cultures correlate well with osseous cultures and provide a sensitive method in 
assessing and targeting likely pathogens that cause osseous infections.  This will help aid the 
clinician in guiding antibiotic therapy” (Malone, Bowling, et. al, 2013, p. 546).  The wound 
cultures that they used were specifically from deep wounds or taken from in wound sinus 
tracts (Malone, Bowling, et. al, 2013, p. 549).  Another diagnostic tool that relates to the 
pathophysiology of osteomyelitis and inflammation is the increase in inflammatory markers 
that can be found on diagnostic lab work.  A study that examined the levels of inflammatory 
markers C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cells 
(WBC), and procalcitonin (PCT) in osteomyelitis compared to soft tissue injuries found that all 
inflammatory markers were significantly higher in osteomyelitis (Michail, et. al., 2013, p. 96).  
Furthermore, the study found that ESR was actually the best marker to monitor the response 
to therapy (Michail, et. al., 2013, p. 96).  Surgical intervention may be needed in some cases 
due to failure to respond to antibiotics, infected surgical hardware and chronic osteomyelitis 
with necrotic bone (Hatzenbuehler & Pulling, 2011, p. 1032).  
• Diabetes and osteomyelitis clearly 
coincide so special attention needs 
to be pain to diabetics with chronic 
ulcers and peripheral vascular 
disease 
• Not only do diabetic patients have 
peripheral neuropathy leading to an 
increased risk of not recognizing a 
wound advancing into an infection, 
but they also have “microvascular 
abnormalities and phagocytosis 
defects” which “are likely to facilitate 
the spread of bacterial infection 
throughout the medulla and cortical 
bones” (Senneville, et. al., 2012, p. 
59).  
• Poor glycemic control leads to the 
complications of diabetes that are 
linked to osteomyelitis so better 
glycemic control can limit these 
complications and risk factors.  It can 
be implied that nurses can take an 
active role in diabetic education that 
will truly make a difference in patient 
outcomes in preventing 
osteomyelitis and limiting 
complications from osteomyelitis.  
• Furthermore, nurses can educate 
about other aspects of diabetes 
management such as good foot care, 
need for routine follow-up and 
getting healthcare in a timely 
manner (Malone, Gannass, et. al. 
2013, p. 323). 
American Family Physician, 11/1/2011, Vol. 84 Issue 9, p1027-1033, 7p, 1 Color         
Photograph, 2 Black and White Photographs, 3 Charts 
Color Photograph; found on p1030 
Journal of Wound Care, Jun2013, Vol. 22 Issue 6, p318-323, 5p 
    Color Photograph; found on p320 
Cassat, J. E., Hammer, N. D., Campbell, 
J. P., Benson, M. A., Perrien, D. S., 
Mrak, L. N., & ... Skaar, E. P. (2013). A 
secreted bacterial protease tailors the 
Staphylococcus aureus virulence 
repertoire to modulate bone 
remodeling during osteomyelitis. Cell 
Host & Microbe, 13(6), 759-772. 
doi:10.1016/j.chom.2013.05.003 
Grbic, R., Miric, D. J., Kisic, B., Popovic, 
L., Nestorovic, V., & Vasic, A. (2014). 
Sequential analysis of oxidative stress 
markers and vitamin C status in acute 
bacterial osteomyelitis. Mediators of 
Inflammation, 2014975061. 
doi:10.1155/2014/975061 
Hatzenbuehler, J., & Pulling, T. J. 
(2011). Diagnosis and management of 
osteomyelitis. American Family 
Physician, 84(9), 1027-1033. 
Lipsky, B. A., Berendt, A. R., Cornia, P. 
B., Pile, J. C., Peters, E. G., Armstrong, 
D. G., & ... Infectious Diseases Society 
of, A. (2012). 2012 Infectious Diseases 
Society of America clinical practice 
guideline for the diagnosis and 
treatment of diabetic foot infections. 
Clinical Infectious Diseases: An Official 
Publication of the Infectious Diseases 
Society of America, 54(12), e132-e173. 
doi:10.1093/cid/cis346 
Malone, M., Bowling, F. L., Gannass, A., 
Jude, E. B., & Boulton, A. M. (2013). 
Deep wound cultures correlate well 
with bone biopsy culture in diabetic 
foot osteomyelitis. 
Diabetes/Metabolism Research and 
Reviews, 29(7), 546-550. 
doi:10.1002/dmrr.2425 
Malone, M., Gannass, A., Descallar, J., 
Bowling, F. L., & Dickson, H. G. (2013). 
Pedal osteomyelitis in patients with 
diabetes: a retrospective audit from 
Saudi Arabia. Journal of Wound Care, 
22(6), 318.  
McCance, K. L., Huether, S. E., 
Brashers, V. L., & Rote, N. S. (eds.) 
(2014). Pathophysiology: The biologic 
basis for disease in adults and children 
(7th ed.). St. Louis, MO: 
Elsevier/Mosby. 
Michail, M., Jude, E., Liaskos, C., 
Karamagiolis, S., Makrilakis, K., 
Dimitroulis, D., & ... Tentolouris, N. 
(2013). The performance of serum 
inflammatory markers for the diagnosis 
and follow-up of patients with 
osteomyelitis. The International Journal 
Of Lower Extremity Wounds, 12(2), 94-
99. doi:10.1177/1534734613486152 
Senneville, E., Gaworowska, D., 
Topolinski, H., Devemy, F., Nguyen, S.,  
